More than 18 percent of all lung cancers detected by low-dose computed tomography (LDCT) appeared to represent an overdiagnosis, according to a study published by JAMA Internal Medicine, a JAMA Network publication.
LDCT has been shown in recent clinical trials to be an effective screening tool in some patients, but some of the tumors it finds may be indolent (slow growing) or clinically insignificant. Overdiagnosis is the detection of a cancer with a screening test that wouldn’t otherwise have become clinically apparent. It is a potential harm of screening because of the additional cost, anxiety and complications associated with unnecessary treatment, according to the study background.
Edward F. Patz Jr., M.D., of Duke University Medical Center, Durham, N.C., and colleagues examined data from the National Lung Screening Trial, which compared LDCT screening vs. chest radiography (CXR) among 53,452 people at high risk for lung cancer, to estimate overdiagnosis.
Among 1,089 lung cancers reported in the LDCT group during follow-up, the authors estimated that 18.5 percent represented an overdiagnosis. They also estimated that 22.5 percent of non-small cell lung cancer detected by LDCT represented an overdiagnosis, and that 78.9 percent of bronchioalveolar (air sacs) lung cancers detected by LDCT represented an overdiagnosis.
“In the future, once there are better biomarkers and imaging techniques to predict which individuals with a diagnosis of lung cancer will have more or less aggressive disease, treatment options can be optimized, and a mass screening program can become more valuable,” the authors conclude.
JAMA Intern Med. Published online December 9, 2013. doi:10.1001/jamainternmed.2013.12738.
This research was funded by grants from the National Institutes of Health. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Article adapted by Medical News Today from original press release. Click ‘references’ tab above for source.
Lung Cancer category page for the latest news on this subject.Please use one of the following formats to cite this article in your essay, paper or report:
MLAMedicine, JAMA Internal. “Study suggests overdiagnosis in screening for lung cancer with low-dose CT.” Medical News Today. MediLexicon, Intl., 9 Dec. 2013. Web.10 Dec. 2013. <http://www.medicalnewstoday.com/releases/269848>
APAMedicine, J. (2013, December 9). “Study suggests overdiagnosis in screening for lung cancer with low-dose CT.” Medical News Today. Retrieved fromhttp://www.medicalnewstoday.com/releases/269848.Please note: If no author information is provided, the source is cited instead.
Rate this article (click to rate)
Study suggests overdiagnosis in screening for lung cancer with low-dose CT
Public / Patient:
Add Your Opinion On This ArticleJoin the discussuon
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
Contact our news editors
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Scroll to top
This page was printed from: http://www.medicalnewstoday.com/releases/269848.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.